See All Slides - tctmd.com

Slides

Presentation TCT 2012

TCT-52. Bivalirudin Reduces Cardiac Mortality in Patients with and Without Major Bleeding: The HORIZONS-AMI Trial

Presenter: Gregg Stone

October 23, 2012

Presentation TCT 2012

ELM Presentation(2)

Presenter: Mauricio Cohen

October 23, 2012

Presentation TCT 2012

TCT-56. Incremental Value of Platelet Reactivity Over a Risk Score of Clinical and Procedural Variables in Predicting Bleeding Events After Percutaneous Coronary Intervention

Presenter: Fabio Mangiacapra

October 23, 2012

Presentation TCT 2012

Synthesis of the New ESC LAA Closure Guidelines

Presenter: Peter Sick

October 23, 2012

Presentation TCT 2012

VESTAsync (MIV Therapeutics) Program Update

Presenter: Ricardo Costa

October 23, 2012

Presentation TCT 2012

Nanoparticle-Based Stents 2: FOCUS np (Envision Scientific) Program Update

Presenter: Ashok Seth

October 23, 2012

Presentation TCT 2012

TCT-18. Long-term Outcome of Discordance Between Fractional Flow Reserve and Coronary Flow Velocity Reserve After Deferral of Percutaneous Coronary Intervention

Presenter: Tim van de Hoef

October 23, 2012

Presentation TCT 2012

Year in Review: Preventative Cardiology

Presenter: Donna Polk

October 23, 2012

Presentation TCT 2012

State-of-the-Field Keynote: The Next Challenge: Improving Technical Efficiency and Biological Response (Nonresponders)

Presenter: Deepak Bhatt

October 23, 2012

Presentation TCT 2012

TCT-103. The Transaortic Approach for Transcatheter Aortic Valve Replacement: Initial Clinical Experience in the United States

Presenter: Joel Lardizabal

October 23, 2012

Advertisement

Slides

TCT-52. Bivalirudin Reduces Cardiac Mortality in Patients with and Without Major Bleeding: The HORIZONS-AMI Trial

ELM Presentation(2)

TCT-56. Incremental Value of Platelet Reactivity Over a Risk Score of Clinical and Procedural Variables in Predicting Bleeding Events After Percutaneous Coronary Intervention

Synthesis of the New ESC LAA Closure Guidelines

VESTAsync (MIV Therapeutics) Program Update

Nanoparticle-Based Stents 2: FOCUS np (Envision Scientific) Program Update

TCT-18. Long-term Outcome of Discordance Between Fractional Flow Reserve and Coronary Flow Velocity Reserve After Deferral of Percutaneous Coronary Intervention

Year in Review: Preventative Cardiology

State-of-the-Field Keynote: The Next Challenge: Improving Technical Efficiency and Biological Response (Nonresponders)

TCT-103. The Transaortic Approach for Transcatheter Aortic Valve Replacement: Initial Clinical Experience in the United States

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content